Mesa Laboratories (FRA:MLI) Float Percentage Of Total Shares Outstanding: 68.72% (As of Jul. 02, 2026)


FRA:MLI Mesa Laboratories Inc FRA:MLI
77 GF Score
Price €86.50
GF Value €96.24
! 8 Warning Signs
View Full Analysis

What is Mesa Laboratories Float Percentage Of Total Shares Outstanding?

Mesa Laboratories FRA:MLI 77 Float Percentage Of Total Shares Outstanding is 68.72% as of Jul. 02, 2026. GuruFocus rates FRA:MLI with a GF Score™ of 77/100 and a GF Value™ of €96.24. The stock has 8 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mesa Laboratories's float shares is 3.79 Mil. Mesa Laboratories's total shares outstanding is 5.52 Mil. Mesa Laboratories's float percentage of total shares outstanding is 68.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mesa Laboratories's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mesa Laboratories's Institutional Ownership is 55.47%.

FRA:MLI
77GF Score
Mesa Laboratories Inc FRA:MLI
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mesa Laboratories Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Mesa Laboratories's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=3.79/5.52
=68.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 68.72% mean?
Mesa Laboratories (FRA:MLI) has a Float Percentage Of Total Shares Outstanding of 68.72% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Mesa Laboratories and its competitors.
Is Mesa Laboratories' Float Percentage Of Total Shares Outstanding too high?
Mesa Laboratories' current Float Percentage Of Total Shares Outstanding is 68.72%. Overall, Mesa Laboratories has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Float Percentage Of Total Shares Outstanding compare to AERG and USBC?
Mesa Laboratories' Float Percentage Of Total Shares Outstanding of 68.72% can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Hardware company?
A good Float Percentage Of Total Shares Outstanding depends on the Hardware industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Mesa Laboratories and its competitors. Mesa Laboratories's current Float Percentage Of Total Shares Outstanding is 68.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Mesa Laboratories (FRA:MLI) has a current Float Percentage Of Total Shares Outstanding of 68.72%. The stock's GF Value™ is €96.24, compared to a current price of €86.50 — trading 10.1% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 68.72%. Mesa Laboratories' overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Mesa Laboratories (FRA:MLI), the current Float Percentage Of Total Shares Outstanding is 68.72% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mesa Laboratories (FRA:MLI) Overvalued in 2026?

Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued. The current stock price of €86.50 is trading 10.1% below its estimated GF Value™ of €96.24.

Key valuation signals for FRA:MLI:

  • Float Percentage Of Total Shares Outstanding: 68.72%
  • GF Value™: €96.24 vs. price of €86.50 (10.1% below fair value)
  • GF Score™: 77/100 with 8 warning signs

No single metric tells the full story. See the FRA:MLI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mesa Laboratories Business Description

Other Exchanges MLAB:USA
Address 12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score

Get the complete analysis for FRA:MLI

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€86.50
Price
€96.24
GF Value